Adam Cias

Orthocell is a regenerative medicine company dedicated to the development of breakthrough products to unlock the power of the human body to heal - restoring mobility, function and performance. Orthocell produces two complementary platform products – a collagen medical device and autologous cell therapies. CelGro™ platform of collagen medical devices are designed to augment surgical repair of bone, nerve, tendon and cartilage. The Company’s cell therapies include autologous tendon therapy and autologous chondrocyte implantation (OrthoACI™), which aim to regenerate damaged tendon and cartilage tissue.